Papular mucinosis associated with scleroderma

European Journal of Dermatology

Volumn 8, Issue 7, 1998, Pages 497-500

  Sawada, Yoko ^a   Seishima, Mariko ^a   Funabashi, Miyuki ^a   Noda, Tokuro ^a   Maeda, Manabu ^a   Kitajima, Yasuo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Papular mucinosis; Prostaglandin; Psychosis; Scleroderma; Scleromyxedema

Indexed keywords

AMITRIPTYLINE; ANTINUCLEAR ANTIBODY; ETIZOLAM; IMMUNOGLOBULIN G; MUCIN; PROSTAGLANDIN E1 DERIVATIVE; SULPIRIDE;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CELL INFILTRATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERIMMUNOGLOBULINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MUCINOSIS; PAPULE; PATHOPHYSIOLOGY; RAYNAUD PHENOMENON; SCLERODERMA;

ALPROSTADIL; BIOPSY, NEEDLE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; MUCINOSES; MUCINS; SCLERODERMA, LOCALIZED; SKIN; TREATMENT OUTCOME;

EID: 0031667762     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Helfrich DJ, Walker ER, Martinez AJ, Medsger TA Jr. Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum 1988; 31: 1437-9.
2. Black MM. Mucinoses. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology 5th edition. London: Blackwell Scientific Publications, 1992: 2325-6.
3. Lai A, Fat RF, Suurmond D, Radl J, van Furth R. Scleromyxoedema (lichen myxedematosus) associated with a paroprotein, IgG1 of type kappa. Br J Dermatol 1973; 88: 107-16.
4. Wright RC, Franco RS, Denton D, Blaney DJ. Scleromyxedema. Arch Dermatol 1976; 112: 63-6.
5. Rongioletti F, Rebora A. Papular and nodular mucinosis associated with systemic lupus erythematosus. Br J Dermatol 1986; 115: 631-6.
6. Egawa H, Abe-Matsuura Y, Tada J, Arata J. Nodular cutaneous lupus mucinosis associated with atrophic blanche-like lesions in a patient with systemic lupus erythematosus. J Dermatol 1991; 21: 674-9.
7. Pandya AG, Sontheimer RD, Cockerell O, Takashima A, Piepkorn M. Papulonodular mucinosis associated with systemic lupus erythematosus: possible mechanisms of increased glycosaminoglycan accumulation. J Am Acad Dermatol 1995; 32: 199-205.
8. Giménez Garcia R, Gil Garcia S, Suarez Vilela D, Moro Sanchez MJ. Scleromyxedema associated with non-Hodgkin lymphoma. Int J Dermatol 1989; 28: 670-1.
9. Archibald GC, Calvert HT. Hypothyroidism and lichen myxoedematosus. Arch Dermatol 1977; 113: 884-5.
10. Kantor GR, Bergfeld WF, Katzin WE, Reynolds OD, Biscardi AP, Lobur DM, Box TA, Schreiber MJ Jr, Ratliff NB. Scleromyxedema associated with scleroderma renal disease and acute psychosis. J Am Acad Dermatol 1986; 14: 879-88.
11. Harris RB, Perry HO, Kyle RA, Winkelmann RK. Treatment of scleromyxedema with melphalan. Arch Dermatol 1979; 115: 295-9.
12. Buckingham RB, Prince PK, Rodnan GP Taylor F. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J Lab Clin Med 1978; 92: 5-21.
13. Rowell NR, Goodfield MJD. Systemic sclerosis. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology 5th edition. London: Blackwell Scientific Publications, 1992: 2241-6.
14. Rongioletti F, Gambini C, Micalizzi C, Pastorino A, Rebora A. Mucin deposits in morphea and systemic scleroderma. Dermatology 1994; 189: 157-8.
15. Barnett AJ, Coventry DA. Scleroderma: clinical features, course of illness and responses to treatment in 61 cases. Med J Aust 1969; 1: 992-1001.
16. LeRoy EC, Black C, Fleishmajer R, Jablonska S, Krieg TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
17. Maeda M, Matsubara K, Kachi H, Mori S, Kitajima Y. Histopathological and capillaroscopical features of the cuticles and bleeding clots in ring or middle fingers of systemic scleroderma patients. J Dermatol Sci 1995; 10: 35-41.
18. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995; 33: 37-43.
19. Rongioletti F, Rebora A. Acral persistent papular mucinosis: a new entity. Arch Dermatol 1986; 122: 1237-9.
20. Flowers SL, Cooper PH, Landes HB. Acral persistent papular mucinosis. J Am Acad Dermatol 1989; 21: 293-7.
21. Borradori L, Aractingi S, Blanc F, Verola O, Dubertret L. Acral persistent papular mucinosis and IgA monoclonal gammopathy: report of a case. Dermatology 1992; 185: 134-6.
22. Truhan AP, Roenigk HH Jr. The cutaneous mucinosis. J Am Acad Dermatol 1986; 14: 1-18.
23. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro. J Clin Invest 1974; 54: 880-9.
24. Uitto J, Bauer EA, Eizen AZ. Increased biosynthesis of triple-helical type I procollagen associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest 1979; 64: 921-30.
25. Kahari VM, Heino J, Larjava H, Vuorio E. Alteration in scleroderma fibroblasts surface glycoproteins associated with increased collagen synthesis. Acta Derm Venereol (Stockh) 1987; 67: 199-205.
26. Ohta A, Uitto J. Procollagen gene expression by scleroderma fibroblasts in culture: inhibition of collagen production and reduction of pro-α 1(1) collagen messenger RNA steady-state levels by retinoids. Arthritis Rheum 1987; 30: 401-11.
27. Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem 1987; 262: 6443-6.
28. Ivarsson M, McWhirter A Black CM, Rubin K. Impaired regulation of collagen pro-α 1(1) mRNA and change in pattern of collagen-binding integrins on scleroderma fibroblasts. J Invest Dermatol 1993; 101: 216-21.
29. Fleischmajer R, Perlish JS. Glycosaminoglycans in scleroderma and scleredema. J Invest Dermatol 1972; 58: 129-32.
30. Uitto J, Helin G, Aelin P, Lorenzen I. Connective tissue in scleroderma, a biochemical study on the correlation of fractionated glycosaminoglycans and collagen in human skin. Acta Derm Venereol (Stockh) 1971; 51: 401-6.
31. Harper RA, Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science 1978; 199: 545-7.